glp-1 drugs for obesity What's New in Treatment? The GLP-1 revolution: What UAB
Description
Int J Mol Sci (2019) 20(21):5407

Wegovy (semaglutide), which was approved in 2021 (it was previously available for diabetes as Ozempic and in an oral form for diabetes as Rybelsus)

doi: 10.1016/j.jcjd.2019.09.003 110 HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet al

Bunck, M.C

The efficacy was similar in monotherapy and in combination with other agents
